Company / Working Capital per Share
TScan Therapeutics, Inc. Working Capital per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.24
FY2025
5-year range
$1.24 / $157.54
FY2021-FY2025
Trend
-68.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 4 consecutive years, from $157.54 in FY2021 to $1.24 in FY2025.
Based on SEC 10-K filings.
1.24 in FY2025 with a 3-year CAGR of -48.7%.
Declined from $6.84 to $1.24 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -48.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TScan Therapeutics, Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 68.4% year-over-year.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.24 | -68.4% |
| FY2024 | $3.91 | -42.8% |
| FY2023 | $6.84 | -25.4% |
| FY2022 | $9.16 | -94.2% |
| FY2021 | $157.54 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026